ME

23andMe is a pioneering personal genomics and biotechnology company that leverages the world's largest database of genotypic and phenotypic data to drive drug discovery. The company is best known for its direct-to-consumer DNA testing kits, which provide ancestry and health reports to millions of customers worldwide. Beyond its consumer business, 23andMe operates a therapeutics division that identifies novel drug targets using its proprietary research platform. Its clinical pipeline focuses on immuno-oncology, with lead programs targeting the CD96 and PVRIG pathways to enhance the immune system's ability to fight cancer. The company maintains a significant strategic collaboration with GSK, which includes joint drug discovery efforts and the development of genetically validated therapies.